Judith E. Heida - Publications

The association of urinary epidermal growth factors with ADPKD disease severity and progression.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: October 03, 2022

Author's Reply to Correspondence: "Effect of Tolvaptan Treatment on Acid-Base Homeostasis in ADPKD Patients".

Journal: Kidney international reports

Published: April 12, 2021

The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial.

Journal: Journal of the American Society of Nephrology : JASN

Published: October 27, 2020

Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients.

Journal: Kidney international reports

Published: October 01, 2020

Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: June 27, 2020

Effect of Vasopressin on the Hypothalamic-Pituitary-Adrenal Axis in ADPKD Patients during V2 Receptor Antagonism.

Journal: American journal of nephrology

Published: June 25, 2020

No Change in Nocturia After NOCTURNE.

Journal: Kidney international reports

Published: June 11, 2020

Use of copeptin in the diagnosis of polyuria-polydipsia syndrome.

Journal: Lancet (London, England)

Published: August 20, 2019

The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels.

Journal: Kidney international reports

Published: August 24, 2016

Comparison of ex vivo stability of copeptin and vasopressin.

Journal: Clinical chemistry and laboratory medicine

Published: June 24, 2016